Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Celprogen, Inc logo — company profile

Celprogen, Inc

Founded 2002 United States San Pedro, United States 5 employees Biotechnology

General Information

Company Name Celprogen, Inc
Founded Year 2002
Location United States San Pedro, United States +1
Employees 5
Industries Biotechnology
Social

Get notified when Celprogen, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Celprogen, Inc

Celprogen, Inc is a biotechnology company, founded in 2002, that has made significant strides in the field of regenerative medicine. The company offers over 5000 products, including stem cells, cancer stem cells, iPC’s & media with specific ECM’s, all manufactured in the United States of America. Celprogen is dedicated to developing stem cell research and therapeutics products, focusing on cardiology, oncology, diabetes, and neurology. The company has three divisions: Therapeutic Division, Life Science Division, and Device Division, each catering to specific aspects of biotechnology and pharmaceutical research. Celprogen's innovative molecular diagnostics and therapeutic product development solutions have established the company as a key player in the biotechnology industry. With its focus on drug discovery, research tools, and novel assay systems, Celprogen is positioned as a strategic partner for academic research and pharmaceutical communities. As a potential investment opportunity, Celprogen presents a compelling proposition in the rapidly advancing field of regenerative medicine and biotechnology.

No funding data available for Celprogen, Inc yet.

Get notified when Celprogen, Inc raises funding

Celprogen, Inc Alternatives & Competitors

Celprogen, Inc vs
ScienCell Research Laboratories
ScienCell Research Laboratories United States

Helping the Scientists of Today Discover the Science of Tomorrow

49 employees
Biotechnology, Clean Energy
Celprogen, Inc vs
Diasorin
Diasorin Italy

Diasorin is an Italian multinational biotechnology company that produces and markets in vitro diagno...

2113 employees
Celprogen, Inc vs
Cell Applications, Inc.
Cell Applications, Inc. United States

Global Leadership in Primary Cells: Excellence in cell isolation, 3D bioprinting, tissue engineering...

17 employees
Biopharma, Biotechnology

FAQ About Celprogen, Inc

Founded in 2002, CELPROGEN is a biotechnology company, with over 5000 products in the market, focused on developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, canc...
Celprogen, Inc was founded in 2002.
Celprogen, Inc is headquartered in San Pedro, United States.
Celprogen, Inc operates in the following industries: Biotechnology.
Celprogen, Inc has approximately 5 employees.
Top alternatives and competitors to Celprogen, Inc include ScienCell Research Laboratories, Diasorin, Cell Applications, Inc., Ansh Labs, a VION Biosciences company, BrainXell. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celprogen, Inc and ScienCell Research Laboratories are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Celprogen, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy